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1. Introduction 
Fibroblast Growth Factor (FGF) signaling plays a vital role in a wide range of cellular 
responses (Detillieux et al., 2003; Freeman et al., 2003).  The activation of FGF Receptor 
(FGFR) is a crucial step in the diverse FGF signaling pathway ( Ayari & Soussi-Yanicostas, 
2007). Various intra- and extracellular modulators are involved in the FGF signaling 
pathway.  Anosmin-1, an extracellular matrix associated glycosylated protein, is a newly 
identified modulator of the FGF-mediated signaling process (Bribian et al., 2006; Gonzalez-
Martinez et al., 2004). Anosmin-1 is the product of KAL1 gene.  The Kallman syndrome (KS) 
is a manifestation of the different loss-of-function mutations in the KAL1 gene. The most 
characteristic features of the Kallman syndrome are anosmia (lack of smell) and 
hypogonadotrophic hypogonadism (Maestre, 1856; Kallmann et al., 1944).  The biological 
role(s) of Anosmin-1 has been studied both at the cellular and at the biochemical level.  
Anosmin-1 is suggested to be involved in cell adhesion, cell migration, cell proliferation as 
well as cell differentiation (Andrenacci et al., 2004; Andrenacci et al., 2006; Ardouin et al., 
2000; Bribian et al., 2006; Cariboni et al., 2004; Ernest et al., 2007; Hardelin et al., 1999; Hu et 
al., 2004; Okubo et al., 2006; Robertson et al., 2001; Rugrali et al., 1996; Soussi-Yanicostas, 
1996; Soussi-Yanicostas et al., 1998; Soussi-Yanicostas et al.,  2002; Yanicostas et al., 2008;).  
Anosmin-1 is shown to be a heparin binding protein and formation of the heparin-Anosmin 
binary complex is believed to be crucial for the function of the protein (Bulow et al., 2002).  
Interestingly, recent reports suggest a direct interaction between the N- terminus of 
Anosmin-1 and the FGF-2/FGFR-1/HS ternary complex (Hu et al., 2009; Hu & Bouloux, 
2010).   
The structure of Anosmin-1(Figure 1) comprises of an N-terminal cysteine-rich domain 
(CR), whey acidic like-protein domain (a-WAP), four fibronectin type III (FnIII) repeats and 
C-terminal histidine rich region.  Recent reports suggest direct interactions of some of the 
structural domains of Anosmin-1, including a-WAP, with the fibroblast growth factor 
receptor(s).  Although the Anosmin-FGFR binding interface is still not mapped, it is strongly 
believed that the interactions of Anosmin-1 with FGFR(s) regulates the activation of the 
receptor.  
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Fig. 1. Schematic representation of human full length Anosmin-1 protein with all the 
domains, the a-WAP domain labeled in red color spans from 127 to 176 amino acid. 
Evolutionarily, Anosmin-1 sequences show the highest conservation within the N-terminal 
a-WAP and the FnIII-1 domain.  Therefore, it is contemplated that these structural domains 
are functionally significant.  The WAP domain of Anosmin-1 (a-WAP) contains 8 cysteine 
residues which are disulphide bonded to form the four-disulphide core (FDSC) (Figure 2).  
Most of the proteins containing WAP domain exhibit protease inhibitory activity and 
consequently regulate the cell proliferation, cell differentiation and tissue remodeling 
processes (Whitlock et al., 2005).  In marked contrast, Anosmin-1 containing the a-WAP 
domain has been shown to promote the uPA (uro-plasminogen activator) proteolytic 
activity (Hu et al., 2004). 
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Fig. 2. Panel A. depicts the amino acid sequence of full length Anosmin-1.  Residues, 127-
176, (shown in red) spans the a-WAP domain with eight conserved cysteines involved in the 
intra FDSC(four-disulphide core) motif that are highlighted in blue.  
Panel B. shows the highly conserved intramolecular disulphide bonding pattern in the a-
WAP domain. 
Some of the mutations in the a-WAP domain are believed to lead to the loss of functions of 
Anosmin-1.  Missense mutations of C172R or C163Y in the KS patients are predicted to 
result in the disruption of the conserved disulphide bonds and consequently affecting the 
stability and folding of the protein (Hu et al., 2004).  The present study is aimed at 
understanding the structure-function relationship of the a-WAP domain of Anosmin-1.   
Therefore, significant quantities of protein(s) are required to embark on detailed structure-
function relationship studies.  With the advent of the recombinant DNA technology, over-
expression of recombinant proteins in heterologous hosts has been rendered easy.  Among 
the expression hosts, Escherichia coli (E.coli) is an apt choice because it is one of the best 
www.intechopen.com
 Molecular Cloning and Overexpression of WAP Domain of Anosmin–1 (a–WAP) in Escherichia coli 
 
61 
studied model systems which is not only easy to handle but is also known to produce 
recombinant proteins in high yields.  
In general, proteins of interest are cloned into a suitable expression vector and 
overexpressed under selected induction conditions.  One of the most successful bacterial 
expression vectors available is the pGEX system.  We have quite successfully cloned a 
number of genes/DNA segments into this vector and expressed them as soluble GST fusion 
proteins in milligram quantities from a liter of bacterial culture.   In this chapter, we 
summarize the procedure used to clone, overexpress and purify the a-WAP domain of 
Anosmin-1.  The method described can be applied to most other recombinant proteins that 
are difficult to be expressed in the soluble fraction. 
2. Materials and methods 
2.1 Cloning 
• pGEX-KG’ vector (Genentech, USA).  
• BL21 (DE3) ( New England Bio labs) 
• DH5ǂ  (New England Bio labs) 
• Mini prep plasmid isolation kit (QIAGEN, USA)  
• Phusion PCR Master mix Kit (New England Bio Labs) 
• Agarose gel electrophoresis buffer: 0.5X TAE buffer: Tris-acetate (20 mM; pH 8.0), 
EDTA (0.5 mM). 
2.2 Protein expression 
• LB (Luria-Bertani) medium (EMD Chemicals Inc.) for bacterial cultures: Dissolve 25g in 
1L deionized water and autoclave at standard conditions. 
• Ampicillin (Cellgro®): stock solution of 100 mg/ml was prepared and stored at  
-20 °C. 
• Isopropyl ǃ-D-thiogalactoside (IPTG) (Research Products International Corp.):  1M 
stock solution was prepared and stored at -20 °C.  
• SDS PAGE electrophoresis buffer: 1X Tris-glycine buffer – trizma base (25 mM), glycine 
(50 mM), SDS (0.1%), final pH pH 8.3. 
• Staining solution for SDS PAGE: Coomassie Brilliant Blue R-250 (0.25%) in destaining 
solution. 
• Destaining solution for SDS PAGE: methanol (30%), glacial acetic acid (10%). 
• 4X SDS gel-loading Buffer: Tris.HCl (100 mM; pH 6.8), SDS (4%), bromophenol blue 
(0.2%), glycerol (20%), β-Mercapthoethanol (200 mM). 
2.3 Protein purification 
• Phosphate Buffered Saline (1xPBS): Na2HPO4 (10 mM), KH2PO4 (2 mM), NaCl (137 
mM), KCl (2.7 mM), final pH 7.2. 
• GSH Sepharose® beads (GE Health care) are used as affinity based chromatography. 
• Thrombin (Sigma) is dissolved in 2mL of 1xPBS pH 7.2 to obtain a concentration of 
1U/µL. 
• Thermo scientific FH 100 Peristaltic Pump was used for loading the buffers on the 
column. 
• Purification was monitored using UV detector from BIORAD. 
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2.4 Cloning of a-WAP into the pGEX-KG expression vector 
The pGEX-KG (Figure 3) vector from GE Healthcare was used for the expression of the gene 
of interest as the fusion protein with an N-terminal sequence of glutathione S-transferase 
(GST).  The fusion protein can be cleaved with thrombin (cleavage sequence Leu-Val-Pro-
Arg--Gly-Ser) to obtain the recombinant protein with a 15 extra amino acids at the N-
terminus.  
The multiple cloning site (MCS) of this pGEX-2T contains only three sites for cloning: 
BamH1, SmaI, and EcoRI.  To enhance the MCS, the pGEX-2T vector was linearized with 
EcoRI and was ligated to a cassette containing an expanded multiple cloning site (MCS) to 
produce a vector termed pGEX-KG’. The sequence of the MCS is shown (Figure 4).  
Therefore, the sequence beyond the cleavage site for thrombin in the pGEX-KG’ vector will 
code for: Leu-Val-Pro-Arg--Gly-Ser-Pro-Gly-Ile-Ser-Gly-Gly-Gly-Gly-Gly-Ile-Asp-Ser-Met-
Gly-Arg-Leu-Glu-Leu-Lys- (continues further along).  The NcoI site cuts between the Ser-
Met residues and the XhoI site cuts between the Leu-Glu residues. The NcoI and XhoI sites 
were used for cloning the a-WAP gene of Anosmin-1.  
 
 
pGEX-2T vector carries ampicillin resistance, pBR322 origin of replication, Lac promoter and GST tag at 
the 5’ end of the MCS. 
Fig. 3. Vector Map of pGEX-2T 
 
 
Fig. 4. MCS of the pGEX-KG vector 
www.intechopen.com
 Molecular Cloning and Overexpression of WAP Domain of Anosmin–1 (a–WAP) in Escherichia coli 
 
63 
2.5 PCR-based cloning of a-WAP 
The gene of interest was amplified from the optimized E.coli codon human full-length 
Anosmin-1 stabilized in pUC19 (GeneArt, Life technologies, USA) by using gene-specific 
primers a-WAP-FP (5’ACT GCCATGGTGCTGGTGAAACAGG3’) and a-WAP-RP (5’ 
ACTGCTCGAGTTTCGGAACCTGACAG 3’).  The PCR conditions were as described in the 
manufacturer’s protocol with the following modifications: DNA (50 ng -200 ng), forward 
and reverse primers (0.5µM each), 2xPhusion Flash PCR Master Mix (1x) (New England 
Biolabs) were added to a 20 µl reaction mixture.  The samples were incubated in a Master 
cycler Gradient (Eppendorf) for an initial denaturation (10sec.; 98ºC) followed by 30 cycles 
each including denaturation (2sec.; 98ºC), annealing (5 sec.; 62ºC), extension (15sec.; 72ºC), 
and the final extension (1min.; 72ºC).  The PCR product was checked by agarose gel 
electrophoresis.  
The PCR product was purified using a Qiagen PCR purification column according to the 
manufacturer’s instructions to get rid of the unused primers, nucleotides and other material.  
The purified PCR product and pGEX-KG vector were subjected to double digestion with 
NcoI and XhoI. The digested PCR product and the vector were gel purified and were 
subjected to ligation reaction using the Rapid Ligation kit from MBI Fermentas. Conditions 
for agarose gel resolution, recovery of insert from gel slices, quantification, and ligation 
were as per standard cloning protocols. Ligation mixtures were used for transformation of 
DH5ǂ chemical competent cells (New England Biolabs). Recombinant plasmids were 
purified from bacterial colonies and subjected to restriction analyses and DNA sequencing 
to confirm their identity.  
2.6 Expression and purification of recombinant GST-a-WAP fusion protein in E.coli 
The plasmid containing recombinant a-WAP was transformed into E. coli BL21 (DE3) cells.  
A single colony was inoculated into 10 ml LB broth containing   ampicillin (100µg/ml) and 
incubated at 37 ºC overnight.  For large scale expression, LB broth containing ampicilin 
(100µg/ml) was inoculated with 5% (v/v) overnight culture and incubated at 37 °C and 250 
rpm.  Once the OD600 reached 0.8, 1 mM IPTG was added to the cells, which were further 
incubated for four hours. Cells were harvested at 6000 rpm for 20 minutes at 4 °C using 
Beckman JA-10 rotor.  The pellets were washed using 1x PBS and either were used 
immediately or stored at -20 oC.  
E. coli cells containing recombinant GST-a-WAP protein were resuspended in 20 mL of 
1xPBS.  The suspension was lysed using French press at a pressure of 1000 psi.  Cell debris 
was removed by centrifugation at 20000 rpm for 20 min. at 4ºC using Beckman JA-20 
rotor.  
The supernatant was loaded on to the pre-equilibrated (1xPBS) GSH-Sepharose column at 
a flow rate of 1ml/min. After loading the supernatant on the column, the column was 
washed with 1xPBS until a flat baseline was reached. Quantity of thrombin to be used for 
complete cleavage was standardized based on experiments involving in-solution cleavage 
of GST-a-WAP.  For all further purification of a-WAP, thrombin was added at the ratio of 
1U/250µg of recombinant GST-a-WAP protein onto the column for an on-column 
cleavage, which was incubated on the rocker (VWR) at slow speed (45-60 rpm) at room 
temperature for 24hrs.  a-WAP was eluted using 1xPBS and concentrated using Amicon or 
Millipore concentrators.   
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2.7 Determination of protein concentration 
The concentration of the protein was estimated by measuring absorbance at 280nm (ε280nm = 
1.303) using Agilent spectrophotometer.  
2.8 MALDI-MS analysis of the a-WAP 
Prior to MALDI-TOF (Bruker Daltonics) analysis, recombinant a-WAP (~50-100 µg) sample 
was desalted by passing through “ZIPTM” tips (C-18 matrix).  The theoretical molecular 
weight of a-WAP was calculated using ProtParam tool from Expasy and was found to be 
7317.3 Da which was compared with the experimental value obtained from MS-Analysis.  
2.9 Circular Dichorism (CD) analysis 
CD data were recorded as an average of fifteen accumulations at room temperature using a 
Jasco J-720 spectropolarimeter.  Far UV CD spectrum of a-WAP (166 µM) in 1xPBS pH 7.2 
was recorded using a quartz cell of 0.1 mm pathlength in the standard sensitivity mode with 
a scan speed of 50 nm per minute.  Appropriate blank corrections were made in the CD 
spectrum.  The CD data are expressed as molar ellipticity (deg.cm2.dmol-1).  
2.10 Differential scanning calorimetry 
Heat capacity of a-WAP was measured as a function of temperature at pH 7.2 using NANO 
DSCIII with a ramping temperature of 10C/min from 100C to 900C.  Thermal denaturation 
scans were performed using a protein (a-WAP) concentration of ~ 160 µM. The protein 
solution was degassed in 1xPBS, pH 7.2 prior to acquisition of DSC data.  Both the heating and 
cooling cycles were recorded to examine the reversibility of the thermal unfolding process. 
3. Results 
3.1 PCR amplification and cloning of a-WAP 
Human full length Anosmin-1 gene nucleotide sequence was codon optimized with respect to 
E.coli. The Anosmin-1 gene was cloned in the pET-20b vector.  The expression yield(s) of the 
protein was not as expected and therefore each individual structural domain of the Anosmin-1 
gene was cloned and overexpressed in E.coli.  The significantly different structural and also 
functional properties of the a-WAP domain of Anosmin-1, as compared to the WAP domains 
in other proteins, directed our interest to embark on the cloning, overexpression, purification, 
and biophysical characterization of the a-WAP domain. The actual size of the a-WAP  domain 
is 150 bp but after the PCR amplification the product size increased to 170 bps due to the 
addition of 10bps at the 5’ and 3’end that includes the desired restriction sites. This 170 bp 
NcoI – XhoI fragment was cloned into pGEX-KG’ expression vector (please see methods for a 
description of this expression vector) so that the coding sequence of a-WAP would be in-frame 
with the GST coding sequence of this vector. This would allow the expression of a GST-a-WAP 
fusion protein from the pTac promoter (T7 and Lac promoter) of the vector. The colonies 
obtained after transformation were checked for the positive clones using colony PCR, and 
plasmid isolated from the positive clones were confirmed by DNA sequencing. 
3.2 Overexpression of a-WAP 
E. coli BL-21 (DE3) cells transformed with pGEX-KG’-a-WAP were grown in the presence of 
1mM IPTG to induce the overexpression of the GST-a-WAP fusion protein.  A protein of ~32 
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kDa appeared to be induced in cultures grown in the presence of IPTG (Figure 5).  The cells 
obtained after induction were collected to check for the presence of a-WAP in either the 
soluble fraction or in the pellet as inclusion bodies.  Therefore, the bacterial pellet obtained 
from induced cells was subjected to cell lysis and both the supernatant and sonicated pellet 
fractions collected after centrifugation was resolved under reduced denaturation conditions, 
showed that the GST-a-WAP was totally expressed in the soluble fraction (Figure 5).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5. Induction and purification of recombinant a-WAP.  Cell lysates obtained before and 
after induction with IPTG were resolved on 15% SDS PAGE and was stained with 
Coomassie Brilliant Blue – R 250. Lane 1:  Broad range molecular marker; Lane 2: lysate of 
uninduced culture; Lane 3: lysate of induced culture showing a overexpressed band 
~32kDa; Lane 4: Pellet of the induced cells after the sonication followed by centrifugation; 
Lane 5: Supernatant obtained from induced cells after the sonication followed by 
centrifugation containing GST-a-WAP. 
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~7kDa 
3.3 One step purification of a-WAP 
a-WAP was purified to homogeneity by a single-step procedure using glutathione-sepharose 
affinity chromatography (Figure 6).  The expression yield of GST-a-WAP was ~16mg/L of the 
induced E.coli culture.  The GST-a-WAP fusion protein recovered from the affinity column was 
subjected to in-solution thrombin cleavage. It was observed that 1U of thrombin cleaved 250 
µg of GST-a-WAP.  The yield of recombinant a-WAP after thrombin cleavage was ~4mg/L of 
the induced E.coli culture(s). The purified a-WAP migrated as a single band corresponding to a 
molecular mass of ~7 kDa on SDS-PAGE under reducing conditions. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6. Purification profile  of  a-WAP: Samples after each step of purification were resolved 
on 15% SDS-PAGE stained with Coomassie Brilliant Blue – R 250 Lane 1: Supernatant 
obtained after sonication; Lane 2: Flow through obtained after binding  of the supernatant 
with 1xPBS pH 7.2;  Lane 3: Sample collected upon elution with 10mM GSH(reduced);  Lane 
4: Sample of  in-solution thrombin cleaved GST-a-WAP containing bands corresponding to 
26kDA GST and also ~7kDA of a-WAP; Lane 5: Molecular weight marker ; Lane 6 : Empty 
lane ; Lane 7: Sample obtained  by eluting the on-column thrombin cleaved (Incubated at 
room temperature for 24hrs) a-WAP using 1x PBS at pH 7.2. 
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3.4 MALDI-MS analysis of a-WAP 
This is one of the most reliable and accurate method for the determination of molecular mass 
of a protein based on the ion mass-to-charge ratio.  The protein obtained after purification was 
in 1X PBS buffer pH 7.2. The protein sample needs to be desalted prior to mass analysis 
because inorganic salts are known to significantly interfere with the ionization process in the 
mass spectrometry experiment(s).  The monoisotopic mass of purified a-WAP from MALDI-
MS analysis was observed to be 7312 Da (Figure 7).  Theoretical molecular weight of a-WAP 
was calculated from the PROTPARAM tool from EXPASY was found to be 7317.3Da. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7. MALDI-MS analysis of the a-WAP domain.   a-WAP MALDI-MS analysis of the 
desalted a-WAP domain showed a peak that corresponds to  a monoisotopic mass of 7312 Da. 
www.intechopen.com
  
Molecular Cloning – Selected Applications in Medicine and Biology 
 
68
3.5 CD analysis of a-WAP 
Far UV Circular Dichorism spectroscopy is a powerful technique that is used for assessing 
the secondary structural elements in proteins.  Far UV CD spectrum of the a-WAP showed 
the characteristic double minima centered at 208 nm and 222 nm suggesting that the 
backbone of the protein is predominantly in a helix conformation.  Interestingly, the 
aromatic amino acid contributions to the far UV CD spectrum, in the wavelength region of 
225 nm to 230 nm, are conspicuously missing. This observation corroborates well with the 
absence of tryptophan and tyrosine residues in the a-WAP domain of Anosmin-1(Figure 8).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 8. CD Spectral Analysis of a-WAP. Far-UV CD profile of 166 µM a-WAP was recorded 
in 1xPBS at pH 7.2 at 250C  showed that the majority of the protein shows helicity. 
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3.6 DSC Analysis of a-WAP 
Folding and unfolding of proteins are accompanied by heat effects which are largely 
exothermic in nature.  Heat of unfolding measures the enthalpy of the process.  Direct 
measurement of heat of unfolding was examined by differential scanning calorimetry.  The 
change in enthalpy as function of temperature yields the specific heat associated with 
protein unfolding.  It can be observed that the Tm (the temperature at which 50% of the 
protein population exists in the denatured state(s) is ~ 75.8 C.  Interestingly, the thermogram 
representing the unfolding is broad suggesting that the two or more states of the protein are 
in equilibrium with each other (Figure 9).  Such thermal transitions are not uncommon for 
proteins, such as the a-WAP domain of Anosmin-1, which are rich in disulfide bonds.   
 
 
 
 
 
 
Temperature (°C)
C
p 
(k
c
a
l/
K
 
m
o
l)
0 10 20 30 40 50 60 70 80 90 100
2.7
2.8
2.9
3
3.1
3.2
3.3
3.4
 
 
 
 
 
 
 
Fig. 9. DSC profile of a-WAP. DSC profile obtained for 166 µM  a-WAP  in 1x PBS pH 7.2. 
The Tm for the transition from the folded to the denatured state(s) of the a-WAP is 75.80C. 
The change in enthalpy and entropy for the denaturation of the a-WAP are 7.5292kcal/mol 
and 0.0216kcal/(K mol), respectively. 
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4. Discussion 
Recently, there is an increasing interest in understanding the structure and function of 
proteins.  This endeavor warrants the design of avenues that facilitate cost effective 
production of recombinant proteins. To-date, E. coli has been the most suitable and 
commonly used heterologous host for production of recombinant proteins. However, its 
use requires two steps: introduction of DNA in to the host cell and efficient expression of 
the target protein.  Therefore, an appropriate choice of the vector needs to be made to 
overexpress the recombinant protein(s) of interest.  To-date, Anosmin-1 has been 
expressed only in eukaryotic hosts. To reach an abundant and inexpensive expression of 
Anosmin-1, for the first time an attempt was made to express the protein in E.coli.  As the 
expression of the full length gene did not result in satisfactory yields of the protein in 
soluble fraction, the cloning and expression of independent structural domains of the 
protein was attempted in a quest to obtain viable yields.  Of all the structural domains of 
Anosmin-1, the N-terminal a-WAP domain has been suggested to play an important role 
in the function of the protein.  In this context, in the present study, the a-WAP domain 
was cloned and overexpressed in E.coli.  All the WAP family proteins exhibit proteolytic 
activity but the a-WAP domain of Anosmin-1 shows anti-protease activity (Hu et al., 
2004).   Interestingly, mutations of the conserved cysteine residues in the a-WAP domain 
result in the Kallman syndrome.  Therefore, detailed characterization of the a-WAP 
domain of Anosmin-1 is crucial for understanding the molecular basis underlying the 
Kallman syndrome.   
To-date, a-WAP domain from Anosmin-1 has been expressed in S2 cells of Drosophila with 
a yield only sufficient for detection by Western blots.  The very meager expression yields 
obtained therein precludes complete structural characterization of the protein using 
biophysical techniques such as X-ray crystallography or multidimensional NMR techniques 
which require substantially high protein concentrations.  In this context, the high yields (~ 4 
mg- 5mg/L of the bacterial culture) of the a-WAP domain obtained using our cloning and 
overexpression strategy is significant. Most importantly, the recombinant a-WAP domain, 
overexpressed and purified using our method, is well-folded with the backbone of the 
protein predominantly in the helical conformation.    
In general, overexpression and purification of small cysteine-rich proteins in heterologous 
bacterial hosts such as E.coli is considered very challenging. However, the results of this 
study clearly show that optimization of the codons and proper choice of the protein 
affinity tag are crucial for the high expression yields of small and cysteine-rich proteins 
such as the a-WAP-domain of Anosmin-1.  In our experience, the GST-tag considerably 
increases the expression yield and most importantly helps in the circumvention of 
problems generally associated due to lack of elaborate post-translational machinery in 
E.coli.  In our opinion, the GST tag has a ‘chaperoning’ effect on the folding of the 
cysteine-rich a-WAP domain. This aspect is quite significant because most of the 
mammalian proteins are known to be produced as inclusion bodies when expressed in 
E.coli.  In addition, from a structural biology point-of-view, production of GST-fused 
small molecular weight proteins is advantageous because the GST-tag does not 
significantly interfere with the different steps involved in the determination of 3D 
solution structures of proteins using multidimensional NMR experiments.  We believe 
that the cloning and expression strategy employed in this study will be generally 
applicable to other small molecular weight, cysteine-rich proteins.   
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5. Conclusions and future trends 
Anosmin-1 is known to play a crucial role in the regulation of the FGF signaling process. 
However, the exact mechanism by which Anosmin-1 regulates the FGF-induced signaling is 
still not understood.  This lacuna in knowledge is primarily due to non-availability of an 
overexpression system to produce Anosmin-1 or any of its structural domains in high 
yields.  The strategy for cloning and overexpression of the a-WAP domain of Anosmin-1,  
discussed in this study, is expected to provide the necessary impetus for  future structural 
studies aimed at understanding the role of the a-WAP domain of Anosmin-1 in the 
regulation of the FGF receptor activation.   This is a significant accomplishment because the 
a-WAP domain of Anosmin-1 is believed to modulate the FGF-receptor interaction due to its 
high affinity to bind to heparin. Understanding the structure-function of the a-WAP domain 
of Anosmin-1 is expected to provide important clues for the rational design of therapeutic 
principles against a multitude of FGF-mediated pathogenesis.  In general, the cloning and 
overexpression strategy reported in this study is expected to be extremely useful for many 
other small mammalian proteins.  
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